Featured Content

Beta-blockers May Prevent Stress-induced Lung Cancer Treatment Resistance

The results of this study support previous findings that psychological distress is associated with an increased risk of mortality among patients with lung cancer.

New Data Suggest Potential Role for c-MET Inhibition in EGFR TKI-Resistant NSCLC

c-MET, although rarer than T790M, may be a promising therapeutic target for patients who progress on EGFR TKI therapy.

Genetic Predisposition to Cancer: Where Are We Now?

In part 2 of a 2-part series, Bryant Furlow discusses advances in genome sequencing technologies and the resulting insights into associations between inherited germline mutations ...

Mobile Apps: The Future of Cancer Care?

From anxiety and pain self-management to side effect monitoring in clinical trials, mobile applications are revolutionizing oncology. Researchers say the technology is even transforming clinical ...

Durvalumab: Previous Findings and Current Research

Several ongoing clinical trials are also evaluating durvalumab as a single agent or in combination with other therapies, such as tremelimumab, and as a first-line ...

More Features>>>

Video Series

Featured Slideshow

Targeted Therapy for Patients With Lung Cancer

Factors that affect survival, genetic mutations, and more.

Lung Cancer Resources

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters